Neola Medical AB (NEOLA) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.050x

Based on the latest financial reports, Neola Medical AB (NEOLA) has a cash flow conversion efficiency ratio of -0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-3.77 Million ≈ $-406.25K USD) by net assets (Skr75.80 Million ≈ $8.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Neola Medical AB to measure how much of total assets are equity-financed.

Neola Medical AB - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Neola Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NEOLA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Neola Medical AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neola Medical AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tantech Holdings Ltd NASDAQ:TANH	-0.022x
Astrotech Corp NASDAQ:ASTC	-0.228x
Mitra International Resources JK:MIRA	0.005x
Silo Pharma Inc NASDAQ:SILO	-0.145x
Above Food Ingredients Inc. Common Stock NASDAQ:ABVE	0.000x
GREENHY2 Ltd AU:H2G	-0.158x
Fairchild Gold Corp V:FAIR	-0.117x
Heavy Rare EARTHS Ltd AU:HRE	-0.534x

Annual Cash Flow Conversion Efficiency for Neola Medical AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Neola Medical AB from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Neola Medical AB stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr75.80 Million ≈ $8.16 Million	Skr-11.95 Million ≈ $-1.29 Million	-0.158x	-0.34%
2024-12-31	Skr68.96 Million ≈ $7.42 Million	Skr-10.84 Million ≈ $-1.17 Million	-0.157x	-89.83%
2023-12-31	Skr79.03 Million ≈ $8.50 Million	Skr-6.54 Million ≈ $-704.02K	-0.083x	+34.25%
2022-12-31	Skr67.48 Million ≈ $7.26 Million	Skr-8.50 Million ≈ $-914.41K	-0.126x	+26.18%
2021-12-31	Skr40.63 Million ≈ $4.37 Million	Skr-6.93 Million ≈ $-745.89K	-0.171x	+33.89%
2020-12-31	Skr23.55 Million ≈ $2.53 Million	Skr-6.08 Million ≈ $-653.77K	-0.258x	-33.84%
2019-12-31	Skr10.72 Million ≈ $1.15 Million	Skr-2.07 Million ≈ $-222.44K	-0.193x	-94.79%
2018-12-31	Skr13.33 Million ≈ $1.43 Million	Skr-1.32 Million ≈ $-141.95K	-0.099x	--

About Neola Medical AB

ST:NEOLA Sweden Medical Devices

Market Cap

$4.87 Million

Skr45.21 Million SEK

Market Cap Rank

#28601 Global

#646 in Sweden

Share Price

Skr0.58

Change (1 day)

-4.13%

52-Week Range

Skr0.58 - Skr2.39

All Time High

Skr7.54